[1]中国器官移植发展报告(2015—2018)[M]. 黄洁夫. 北京:中国器官移植发展基金会, 2020:7-8. [2]朱志军. 多途径扩展肝移植供肝来源[J]. 基础医学与临床, 2012, 32: 593-597. [3]Nasralla D, Coussios CC, Mergental H, et al.A rando-mized trial of normothermic preservation in liver transplantation[J]. Nature, 2018, 557: 50-56. [4]Thompson ER, Connelly C, Ali S, et al. Cell therapy during machine perfusion[J].Transpl Int, 2021, 34:49-58. [5]Li J, Jia J, He N, et al. Combined kidney-liver perfusion enhances the proliferation effects of hypothermic perfusion on liver grafts via upregulation of IL-6/Stat3 signaling[J]. Mol Med Rep, 2019, 20:1663-1671. [6]Ning H, Jia JJ, Xie HY, et al. Partial inhibition of HO-1 attenuates HMP-induced hepatic regeneration against liver injury in rats[J]. Oxid Med Cell Longev, 2018, 2018:1-11. [7]O'Neill S, Srinivasa S, Callaghan CJ, et al. Novel organ perfusion and preservation strategies in transplantation-where are we going in the united kingdom?[J]. Transplantation, 2020,104:1813-1824. [8]Sakr MF, Zetti GM, Hassanein TI, et al. FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats[J]. Hepatology (Baltimore, Md), 1991, 13: 947-951. [9]Sasaki K, Miyake H, Kinoshita T, et al. Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation[J]. JMI, 2004, 51: 76-83. [10]St Peter SD, Post DJ, Rodriguez-Davalos MI, et al. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplanta-tion[J].Liver Transpl, 2003, 9: 144-149. [11]Pratschke S, Arnold H, Zollner A, et al. Results of the TOP study: prospectively randomized multicenter trial of an ex vivo tacrolimus rinse before transplantation in EDC livers[J]. Transplant Direct, 2016, 2: doi: 10.1097/TXD.0000000000000588. [12]侯建存,李玉民,强喆,等. 缺血预处理对大鼠肝移植早期的保护作用[J]. 基础医学与临床, 2008,28:1317-1318. |